Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia.
This report contains market size and forecasts of Dementia and Movement Disorder Treatment in Global, including the following market information:
Global Dementia and Movement Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Dementia and Movement Disorder Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
MAO Inhibitors (Monoamine Oxidase) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dementia and Movement Disorder Treatment include Pfizer, Novartis, Roche, Teva, Amgen, UCB, H. Lundbeck, Eli Lilly and Allergan and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dementia and Movement Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dementia and Movement Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dementia and Movement Disorder Treatment Market Segment Percentages, by Type, 2021 (%)
MAO Inhibitors (Monoamine Oxidase)
AChE Inhibitors (Acetylcholinesterase)
Glutamate Inhibitors
Global Dementia and Movement Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Dementia and Movement Disorder Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Dementia and Movement Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dementia and Movement Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dementia and Movement Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Dementia and Movement Disorder Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Roche
Teva
Amgen
UCB
H. Lundbeck
Eli Lilly
Allergan
Eisai